353 related articles for article (PubMed ID: 18358472)
1. Effect of phosphodiesterase type 4 inhibitor rolipram on cyclophosphamide-induced cystitis in rats.
Büyüknacar HS; Kumcu EK; Göçmen C; Onder S
Eur J Pharmacol; 2008 May; 586(1-3):293-9. PubMed ID: 18358472
[TBL] [Abstract][Full Text] [Related]
2. Effect of silymarin on bladder overactivity in cyclophosphamide-induced cystitis rat model.
Eser N; Göçmen C; Erdoğan S; Büyüknacar HS; Kumcu EK; Açıkalın A; Önder S
Phytomedicine; 2012 Jun; 19(8-9):840-5. PubMed ID: 22647456
[TBL] [Abstract][Full Text] [Related]
3. Rolipram, a specific type-4 phosphodiesterase inhibitor, inhibits cyclophosphamide-induced haemorrhagic cystitis in rats.
Sakura M; Masuda H; Matsuoka Y; Yokoyama M; Kawakami S; Kihara K
BJU Int; 2009 Jan; 103(2):264-9. PubMed ID: 18710439
[TBL] [Abstract][Full Text] [Related]
4. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
[TBL] [Abstract][Full Text] [Related]
5. Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition.
Oger S; Behr-Roussel D; Gorny D; Denys P; Lebret T; Alexandre L; Giuliano F
Eur Urol; 2007 Mar; 51(3):772-80; discussion 780-1. PubMed ID: 17097801
[TBL] [Abstract][Full Text] [Related]
6. Suppression of detrusor overactivity in rats with bladder outlet obstruction by a type 4 phosphodiesterase inhibitor.
Nishiguchi J; Kwon DD; Kaiho Y; Chancellor MB; Kumon H; Snyder PB; Yoshimura N
BJU Int; 2007 Mar; 99(3):680-6. PubMed ID: 17155980
[TBL] [Abstract][Full Text] [Related]
7. Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats.
Wróbel A; Doboszewska U; Rechberger E; Rojek K; Serefko A; Poleszak E; Skalicka-Woźniak K; Dudka J; Wlaź P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):613-619. PubMed ID: 28220212
[TBL] [Abstract][Full Text] [Related]
8. Type 4 phosphodiesterase inhibitor suppresses experimental bladder inflammation.
Kitta T; Tanaka H; Mitsui T; Moriya K; Nonomura K
BJU Int; 2008 Nov; 102(10):1472-6. PubMed ID: 18410434
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of aminoguanidine against oxidative stress and bladder injury in cyclophosphamide-induced hemorrhagic cystitis in rat.
Abraham P; Rabi S; Selvakumar D
Cell Biochem Funct; 2009 Jan; 27(1):56-62. PubMed ID: 19107871
[TBL] [Abstract][Full Text] [Related]
10. GRC-6211, a new oral specific TRPV1 antagonist, decreases bladder overactivity and noxious bladder input in cystitis animal models.
Charrua A; Cruz CD; Narayanan S; Gharat L; Gullapalli S; Cruz F; Avelino A
J Urol; 2009 Jan; 181(1):379-86. PubMed ID: 19010489
[TBL] [Abstract][Full Text] [Related]
11. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.
Kaiho Y; Nishiguchi J; Kwon DD; Chancellor MB; Arai Y; Snyder PB; Yoshimura N
BJU Int; 2008 Mar; 101(5):615-20. PubMed ID: 18070178
[TBL] [Abstract][Full Text] [Related]
12. Utero-relaxant effect of PDE4-selective inhibitor alone and in simultaneous administration with beta2-mimetic on oxytocin-induced contractions in pregnant myometrium.
Franova S; Janicek F; Visnovsky J; Dokus K; Zubor P; Sutovska M; Nosalova G
J Obstet Gynaecol Res; 2009 Feb; 35(1):20-5. PubMed ID: 19215543
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of the transient receptor potential ankyrin 1 (TRPA1) attenuates hyperalgesia and urinary bladder overactivity in cyclophosphamide-induced haemorrhagic cystitis.
Meotti FC; Forner S; Lima-Garcia JF; Viana AF; Calixto JB
Chem Biol Interact; 2013 Apr; 203(2):440-7. PubMed ID: 23523557
[TBL] [Abstract][Full Text] [Related]
14. Effect of hyaluronic acid on urine nerve growth factor in cyclophosphamide-induced cystitis.
Ho DR; Chen CS; Lin WY; Chang PJ; Huang YC
Int J Urol; 2011 Jul; 18(7):525-31. PubMed ID: 21605172
[TBL] [Abstract][Full Text] [Related]
15. Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder.
Juszczak K; Ziomber A; Wyczółkowski M; Thor PJ
Can J Physiol Pharmacol; 2010 Sep; 88(9):899-906. PubMed ID: 20921976
[TBL] [Abstract][Full Text] [Related]
16. Functional, histological structure and mastocytes alterations in rat urinary bladders following acute and [corrected] chronic cyclophosphamide treatment.
Juszczak K; Gil K; Wyczolkowski M; Thor PJ
J Physiol Pharmacol; 2010 Aug; 61(4):477-82. PubMed ID: 20814076
[TBL] [Abstract][Full Text] [Related]
17. Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats.
Chuang YC; Yoshimura N; Huang CC; Wu M; Chiang PH; Chancellor MB
Eur Urol; 2009 Jul; 56(1):159-66. PubMed ID: 18514386
[TBL] [Abstract][Full Text] [Related]
18. Effect of the rho-kinase inhibitor hydroxyfasudil on bladder overactivity: an experimental rat model.
Masago T; Watanabe T; Saito M; Kinoshita Y; Sato K; Miyagawa I
Int J Urol; 2009 Oct; 16(10):842-7. PubMed ID: 19735460
[TBL] [Abstract][Full Text] [Related]
19. Protein nitration, PARP activation and NAD+ depletion may play a critical role in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis in the rat.
Abraham P; Rabi S
Cancer Chemother Pharmacol; 2009 Jul; 64(2):279-85. PubMed ID: 19015854
[TBL] [Abstract][Full Text] [Related]
20. Involvement of interleukin-6-regulated nitric oxide synthase in hemorrhagic cystitis and impaired bladder contractions in young rats induced by acrolein, a urinary metabolite of cyclophosphamide.
Wang CC; Weng TI; Wu ET; Wu MH; Yang RS; Liu SH
Toxicol Sci; 2013 Jan; 131(1):302-10. PubMed ID: 22961095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
